Notify me when James N. Topper files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PHAT | PHATHOM PHARMACEUTICALS, INC. | Common Stock, $0.0001 par value per share | 8.6% | $70,447,299 | 5,985,327 | 0% | James N. Topper | 01 Nov 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|